Is AMPE or FCPT a better dividend investment in 2026?

AMPE currently yields 1311.05% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: AMPE offers higher current income.

What is the dividend yield difference between AMPE and FCPT?

AMPE has a forward dividend yield of 1311.05% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 1305.00 percentage points.

Home › Compare › AMPE vs FCPT

AMPE vs FCPT: Dividend Comparison 2026

AMPE yields 1311.05% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AMPE wins by $207537754.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AMPE

● Live price

1311.05%

Share price

$0.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$207537754.85M

Annual income

$180,460,634,612,456.80

Full AMPE calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — AMPE vs FCPT

📍 AMPE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AMPE	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AMPE + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AMPE pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMPE

Annual income on $10K today (after 15% tax)

$111,438.87/yr

After 10yr DRIP, annual income (after tax)

$153,391,539,420,588.28/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, AMPE beats the other by $153,391,539,415,679.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMPE + FCPT for your $10,000?

AMPE: 50%FCPT: 50%

100% FCPT50/50100% AMPE

Portfolio after 10yr

$103768877.45M

Annual income

$90,230,317,309,116.05/yr

Blended yield

86.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

AMPE

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-63.7

Piotroski

3/9

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMPE buys

FCPT buys

No recent congressional trades found for AMPE or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAMPEFCPT

Forward yield	1311.05% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$207537754.85M ✓	$49.1K
Annual income after 10y	$180,460,634,612,456.80 ✓	$5,775.28
Total dividends collected	$205538221.53M ✓	$24.1K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: AMPE vs FCPT ($10,000, DRIP)

Year	AMPE Portfolio	AMPE Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1← crossover	$141,805	$131,104.56	$11,401	$700.92	+$130.4K → AMPE
2	$1,889,228	$1,737,497.51	$13,064	$864.84	+$1.88M → AMPE
3	$23,655,368	$21,633,893.61	$15,051	$1,072.48	+$23.64M → AMPE
4	$278,471,869	$253,160,624.79	$17,442	$1,337.22	+$278.45M → AMPE
5	$3,083,213,738	$2,785,248,838.88	$20,340	$1,677.08	+$3083.19M → AMPE
6	$32,119,606,169	$28,820,567,469.38	$23,880	$2,116.57	+$32119.58M → AMPE
7	$314,966,468,315	$280,598,489,713.88	$28,241	$2,689.36	+$314966.44M → AMPE
8	$2,908,568,193,145	$2,571,554,072,047.85	$33,660	$3,442.07	+$2908568.16M → AMPE
9	$25,305,719,846,817	$22,193,551,880,152.03	$40,456	$4,439.95	+$25305719.81M → AMPE
10	$207,537,754,848,551	$180,460,634,612,456.80	$49,063	$5,775.28	+$207537754.80M → AMPE

AMPE vs FCPT: Complete Analysis 2026

AMPE — Stock

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Full AMPE Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this AMPE vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMPE vs SCHD AMPE vs JEPI AMPE vs O AMPE vs KO AMPE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.